DrugPatentWatch Database Preview
ADHANSIA XR Drug Profile
» See Plans and Pricing
Which patents cover Adhansia Xr, and what generic alternatives are available?
Adhansia Xr is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are ten patents protecting this drug.
This drug has twenty-four patent family members in seventeen countries.
The generic ingredient in ADHANSIA XR is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Adhansia Xr
A generic version of ADHANSIA XR was approved as methylphenidate hydrochloride by SPECGX LLC on November 27th, 1998.
Summary for ADHANSIA XR
| International Patents: | 24 |
| US Patents: | 10 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ADHANSIA XR |
| DailyMed Link: | ADHANSIA XR at DailyMed |
US Patents and Regulatory Information for ADHANSIA XR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-004 | Feb 27, 2019 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-003 | Feb 27, 2019 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-005 | Feb 27, 2019 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-006 | Feb 27, 2019 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ADHANSIA XR
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2936748 | Start Trial |
| Chile | 2017001026 | Start Trial |
| Canada | 2936746 | Start Trial |
| Canada | 2936740 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
